News
-
NewsProteoGenix Doubles R&D Facilities to Pave the Way for Minimal Animal Use in Biologics Development
Ana Reis, PhD
ProteoGenix Doubles R&D Facilities to Pave the Way for Minimal Animal Use in Biologics Development July 7, 2022 New facilities support the fast growth and…
-
ProteoGenix, Aseem Healthcare, and Trident Biopharm Solutions Announce a New Antibody Cocktail Effective Against Major Variants of SARS-CoV-2
ProteoGenix, Aseem Healthcare, and Trident Biopharm Solutions Announce a New Antibody Cocktail Effective Against Major Variants of SARS-CoV-2… Read More
-
ProteoGenix Launches New XtenCHOTM Transient CHO Expression System to Improve Biologics Development
ProteoGenix Launches New XtenCHOTM Transient CHO Expression System to Improve Biologics Development March 15, 2022… Read More
-
ProteoGenix Receives European Funding to Develop a Therapeutic Antibody for the Treatment of Inflammatory Rheumatic Diseases
ProteoGenix Receives European Funding to Develop a Therapeutic Antibody for the Treatment of Inflammatory Rheumatic Diseases April… Read More
-
ProteoGenix Boosts the Discovery of Next-Generation Biotherapeutics and Diagnostic Tools
ProteoGenix Boosts the Discovery of Next-Generation Biotherapeutics and Diagnostic Tools June 20, 2020 Schiltigheim, France… Read More
-
ProteoGenix Announces a New Human COVID-19 Antibody Library to Accelerate the Discovery of Potent and Urgently Needed Solutions
ProteoGenix Announces a New Human COVID-19 Antibody Library to Accelerate the Discovery of Potent and Urgently Needed Solutions… Read More
-
ProteoGenix Launches New Human and Rabbit Antibody Libraries to Speed Up the Discovery of Better Therapeutic and Analytical Antibodies
ProteoGenix Launches New Human and Rabbit Antibody Libraries to Speed Up the Discovery of Better Therapeutic and Analytical Antibodies… Read More
